Association between hypoparathyroidism and defective T cell immunity in 22q11.2 deletion syndrome

Journal of Clinical Pathology

Volumn 63, Issue 2, 2010, Pages 151-155

  Herwadkar, A ^a   Gennery, A R ^b   Moran, A S ^a   Haeney, M R ^a   Arkwright, P D ^c  

^a HOPE HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; MITOGENIC AGENT; PHYTOHEMAGGLUTININ;

ARTICLE; BACTERIAL INFECTION; BRONCHIOLITIS; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHROMOSOME 22Q; CHROMOSOME 22Q DELETION SYNDROME; DISEASE ASSOCIATION; ENTERITIS; GENETIC DISORDER; HUMAN; HYPOPARATHYROIDISM; IMMUNE DEFICIENCY; INFECTION RISK; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT INFECTION; THRUSH;

CANDIDIASIS, ORAL; CHILD; CHILD, PRESCHOOL; DIGEORGE SYNDROME; FEMALE; HUMANS; HYPOPARATHYROIDISM; IMMUNITY, CELLULAR; LYMPHOCYTE COUNT; MALE; OPPORTUNISTIC INFECTIONS; PHENOTYPE; RECURRENCE; RETROSPECTIVE STUDIES; T-LYMPHOCYTE SUBSETS; VIRUS DISEASES;

EID: 77349097822     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2009.072074     Document Type: Article

References (13)

1. Sullivan KE. Chromosome 22q11.2 Deletion syndrome: DiGeorge syndrome/velocardiofacial syndrome. Immunol Allergy Clin North Am 2008;28:353-66.
2. Kobrynski LJ, Sullivan KE. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 2007;370:1443-52.
3. Oskarsdottir S, Persson C, Eriksson BO, et al. Presenting phenotype in 100 children with the 22q11 deletion syndrome. Eur J Pediatr 2005;164:146-53.
4. Sullivan KE, Jawad AF, Randall P, et al. Lack of correlation between impaired T cell production, immunodeficiency and other phenotypic features in chromosome 22q11.2 deletion syndromes. Clin Immunol Immunopathol 2008;86:141-6.
5. Müller W, Peter HH, Kallfelz HC, et al. The DiGeorge sequence. II. Immunologic findings in partial and complete forms of the disorder. Eur J Pediatr 1989;149:96-103.
6. Bastian J, Law S, Vogler L, et al. Prediction of persistent immunodeficiency in the DiGeorge anomaly. J Pediatr 1989;115:391- 6.
7. Barrett DJ, Ammann AJ, Wara DW, et al. Clinical and immunologic spectrum of the DiGeorge syndrome. J Clin Lab Immunol 1981;6:1-6.
8. Chinen J, Rosenblatt HM, Smith EO, et al. Long-term assessment of T-cell populations in DiGeorge syndrome. J Allergy Clin Immunol 2003;111:573-9.
9. Knight SC. Control of lymphocyte stimulation in vitro: 'help' and 'suppression' in the light of lymphoid population dynamics. J Immunol Methods 1982;50:R51-63.
10. Shearer WT, Rosenblatt HM, Gelman RS, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Paediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 2003;112:973-80.
11. Su D, Ellis S, Napier A, et al. Hoxa3 and pax1 regulate epithelial cell death and proliferation during thymus and parathyroid organogenesis. Dev Biol 2001;236:316-29.
12. Patel SR, Gordon J, Mahbub F, et al. Bmp4 and Noggin expression during early thymus and parathyroid organogenesis. Gene Expr Patterns 2006;6:794-9.
13. McLean-Tooke A, Barge D, Spickett GP, et al. Immunologic defects in 22q11.2 deletion syndrome. J Allergy Clin Immunol 2008;122:362-7.